Current understanding of peripartum cardiomyopathy.
Heart Failure Prevention and Treatment Program, Salt Lake City, UT 84143, USA. kismet.rasmusson@intermountainmail.org
Kismet D
KD
Rasmusson
D015415:Biomarkers / Q000097:blood; D001706:Biopsy; D002097:C-Reactive Protein / Q000378:metabolism; D009202:Cardiomyopathies / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology / Q000628:therapy; D042241:Early Diagnosis; D005260:Female; D006353:Heart-Assist Devices; D006801:Humans; D015994:Incidence; D020097:Natriuretic Peptide, Brain / Q000097:blood; D010298:Parity; D011181:Postnatal Care; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology / Q000628:therapy; D011295:Prenatal Care; D011379:Prognosis; D011644:Puerperal Disorders / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology / Q000628:therapy; D035583:Rare Diseases; D012307:Risk Factors; D016896:Treatment Outcome; D014336:Troponin / Q000097:blood; D014481:United States / Q000453:epidemiology
D015415:Biomarkers; D014336:Troponin; D020097:Natriuretic Peptide, Brain; D002097:C-Reactive Protein